HIGHLIGHTS
- who: Masafumi Ono from the (UNIVERSITY) have published the research: The association of body mass index with long-term clinical outcomes after ticagrelor monotherapy following abbreviated dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a prespecified sub-analysis of the GLOBAL LEADERS Trial, in the Journal: (JOURNAL)
- what: To unravel the complex intricacies of the GLOBAL LEADERS trial, this study aims to investigate the clinical impact of BMI on the novel antiplatelet strategy with ticagrelor monotherapy in patients undergoing PCI.
- how: Comparison of clinical outcomes between the two antiplatelet strategies in each . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.